43 results on '"Marin-Neto, Jose Antonio"'
Search Results
2. PyBioS: A freeware computer software for analysis of cardiovascular signals
3. Electrical Storm in Chagas Cardiomyopathy: Clinical Predictors, Outcome, and Arrhythmic Characteristics in a Prospective Registry
4. Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy
5. Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease
6. Left Ventricular Scar and Prognosis in Chronic Chagas Cardiomyopathy
7. The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy: Chagas disease, denervation and arrhythmia
8. Chagas Disease
9. Chagas Disease: A Neglected Disease
10. Evaluation of the endothelial glycocalyx damage in patients with acute coronary syndrome
11. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association
12. Pilot study testing the effect of physical training over the myocardial perfusion and quality of life in patients with primary microvascular angina
13. Recommendations for Multimodality Cardiac Imaging in Patients with Chagas Disease: A Report from the American Society of Echocardiography in Collaboration With the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology (DIC-SBC)
14. The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone
15. Randomized Trial of Benznidazole for Chronic Chagasʼ Cardiomyopathy
16. Chagas disease
17. Evaluation and treatment of Chagas disease in the United States
18. Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms
19. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagasʼ cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)
20. Organ Transplantation and Chagas Disease
21. Ultrasonic tissue characterization for patients with Chagas' disease
22. Minor segmental dyssynergy reflects extensive myocardial damage and global left ventricle dysfunction in chronic Chagas disease
23. Prediction of left ventricular wall motion recovery after acute myocardial infarction by Tl-201 gated SPECT: Incremental value of integrated contractile reserve assessment
24. Effects of blood viscosity on proximal flow convergence calculations of regurgitant flow rate and jet dimensions as evaluated by color Doppler flow mapping: An in vitro study
25. Recommendations for Multimodality Cardiac Imaging in Patients with Chagas Disease: A Report from the American Society of Echocardiography in collaboration with the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology (DIC-SBC)
26. Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE)
27. Oclusão percutânea de comunicação interatrial tipo ostium secundum com prótese memopart®
28. Polymorphism in the Alpha Cardiac Muscle Actin 1 Gene Is Associated to Susceptibility to Chronic Inflammatory Cardiomyopathy
29. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification
30. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection
31. Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements
32. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: A substudy from the BENEFIT trial
33. I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica: resumo executivo
34. Abstract 2810: The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of Infarct Zone Viability on Left Ventricular Remodeling After PCI vs. Medical Therapy Alone
35. Pathogenesis of Chronic Chagas Heart Disease
36. The presence of contractile reserve predicts the left ventricular systolic function improvement after prolonged oral dipyridamole use in patients with non-ischemic dilated cardiomyopathy
37. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection
38. Is Left Ventricular Diastolic Thickening Documented During Dobutamine and Pacing Stress Echocardiography Related to Myocardial Ischemia? An Animal Model Study
39. Acute myocardial infarction complicating the clinical course of dilated cardiomyopathy in childhood
40. Antitrypanosomal agents: treatment or threat? – Authors' reply
41. Reversible segmental left ventricular dysfunction caused by accidental administration of sympathomimetic drug in human
42. Curtailment of Cardiac Reserve in Mitral Valve Prolapse
43. I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.